首页> 美国卫生研究院文献>Clinical Molecular Pathology >Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems
【2h】

Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems

机译:膀胱乳头状尿路上皮癌的组织学分级:1998 WHO / ISUP分类系统的预后价值以及与常规分级系统的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aim: To test the prognostic value of the 1998 WHO/ISUP (World Health Organisation/International Society of Urologic Pathology) consensus classification system in Ta papillary urothelial neoplasms of the bladder.>Methods: The histological slides of 322 patients with a primary Ta tumour were classified according to the consensus classification system, and recurrence free survival (RFS) and progression free survival (PFS) were assessed for a mean follow up period of 79 months. In the same patient group, the RFS and PFS rates for the 1973 WHO grading system and a low grade/high grade system were analysed.>Results: Recurrent tumours were seen in all categories of the 1998 WHO/ISUP classification system and five year RFS was not significantly different between the groups (p = 0.12). The five year PFS showed a small but significant difference (p = 0.04) between papillary neoplasms of low malignant potential (PNLMP) and high grade papillary urothelial carcinomas (HGPUCs). In the 1973 WHO classification, no significant difference was found in RFS and PFS between the different grades. In the low grade/high grade classification PFS was significantly better for low grade tumours (p = 0.01).>Conclusion: The prognostic value of the 1998 WHO/ISUP classification system is limited to predicting PFS, especially between PNLMP and HGPUC. The prognostic value of this system over other grading systems is questionable.
机译:>目标:为了测试1998年WHO / ISUP(世界卫生组织/国际泌尿外科病理学会)共识分类系统在膀胱Ta乳头尿路上皮肿瘤中的预后价值。>方法:根据共识分类系统对322例原发性Ta肿瘤患者的组织学切片进行了分类,并评估了无复发生存期(RFS)和无进展生存期(PFS),平均随访期为79个月。在同一患者组中,分析了1973年WHO分级系统和低/高分级系统的RFS和PFS率。>结果:在1998年WHO / ISUP的所有类别中均发现了复发性肿瘤分类系统和五年RFS在两组之间无显着差异(p = 0.12)。五年PFS显示低恶性潜能(PNLMP)的乳头状肿瘤与高度乳头性尿路上皮癌(HGPUCs)之间的差异很小但有显着差异(p = 0.04)。在1973年的WHO分类中,不同等级之间的RFS和PFS没有发现显着差异。在低等级/高等级分类中,PFS对于低等级肿瘤明显更好(p = 0.01)。>结论: 1998 WHO / ISUP分类系统的预后价值仅限于预测PFS,尤其是在PNLMP和HGPUC。该系统相对于其他评分系统的预后价值值得怀疑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号